Antengene to Present Results From Four Cutting Edge Preclinical Studies at AACR 2025 with Focuses Including AnTenGagerTM TCEs and Synthetic Lethality
Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmaceutical ...
The Manila Times10h
OSE Immunotherapeutics Reports Full Year 2024 Financial Results and Provides Corporate Update
"2024 was transformative for OSE, marked by positive efficacy results, major partnerships, and accelerated preclinical ...
Innovent Biologics: Innovent Announces 2024 Annual Results and Business Updates
First-ever positive profit, entering a new era of growth and global innovation SAN FRANSISCO and SUZHOU, China, March 26, 2025 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: ...